Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Xilio Therapeutics (XLO) Shares Outstanding (2024 - 2025)

Historic Shares Outstanding for Xilio Therapeutics (XLO) over the last 2 years, with Q3 2025 value amounting to $51.8 million.

  • Xilio Therapeutics' Shares Outstanding rose 1790.56% to $51.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.8 million, marking a year-over-year increase of 1790.56%. This contributed to the annual value of $45.8 million for FY2024, which is N/A changed from last year.
  • Xilio Therapeutics' Shares Outstanding amounted to $51.8 million in Q3 2025, which was up 1790.56% from $51.8 million recorded in Q2 2025.
  • In the past 5 years, Xilio Therapeutics' Shares Outstanding ranged from a high of $51.8 million in Q3 2025 and a low of $34.5 million during Q1 2024